Pfizer’s CEO says life should “return to normal” within a year, but excludes lifelong re-vaccination because his COVID booster is approved for seniors and high risk. Is rejected.
- Pfizer CEO Albert Bourla said on Sunday that he believes the United States will return to normal within a year.
- His company’s COVID-19 booster shot was approved by the CDC last week for the elderly and endangered individuals.
- Bourla added that the most likely result is that people need to continue to receive the coronavirus booster vaccine each year.
Pfizer CEO Albert Bourla said on Sunday that the United States should return to normal within a year as his COVID-19 booster was approved by the elderly and other high-risk communities. rice field.
“Finally, Moderna’s CEO said this week that the pandemic is about to end in about a year. Do you agree?’ABC This Week’s Host George Stephanapoulos asked Boulla on Sunday.
“I think we can get back to normal life within a year,” he agreed.
“I don’t think this means that the variants won’t last,” Bourla argued. “Basically, I don’t think I should be able to live without vaccination. But that-again, I haven’t seen it yet.”
He receives the coronavirus booster vaccine each year, as well as how people are vaccinated against the flu each year to protect them from the most likely variants of the flu virus of the year, with the most likely consequences. It means we need to continue.
Pfizer CEO Albert Bourla said the United States will return to normal within a year as his company’s booster shot was approved last week for seniors and endangered individuals. Said he thinks
CDC director Rochelle Walensky explained her organization’s decision to dismiss the FDA Advisory Board’s decision that Pfizer boosters should only be given to the elderly and have weakened immunity. The CDC has extended it to individuals living or working in high-risk areas
“The most likely scenario for me is to keep watching new variants emerge as the virus is spreading all over the world,” he said. “And again, we’ll get vaccines-they will last for at least a year.”
“And I think it’s the most likely scenario-it’s an annual re-vaccination, but I really don’t know. We have to wait for the data,” added a pharmaceutical company manager.
Pfizer is the only company in the United States to be approved by the Food and Drug Administration (FDA) for the COVID-19 vaccine and also for boosters.
However, booster shots were only allowed by the FDA to be distributed to seniors over the age of 65 and high-risk individuals such as autoimmune disorders.
The Centers for Disease Control and Prevention rejected the Advisory Board’s decision on Friday, allowing boosters to be distributed to other high-risk individuals, including those living and working in high-risk areas.
CDC director Rochelle Walensky explained on Sunday morning why the public wasn’t approved and why they rejected the FDA’s decision.
“There was a real scientific debate and we called on people at high risk scientifically closely depending on where they lived and where they worked,” she told CBS News “Face the Nation.”
Although 183 million Americans have been fully vaccinated, the number of jabs received has been severely flat during the summer.
President Joe Biden has announced that all companies with more than 100 employees now need to obtain vaccination certification from their workers or undergo at least weekly inspections.
Pfizer’s CEO states that life will “return to normal” within a year, but does not exclude lifelong COVID jabs.
Source link Pfizer’s CEO states that life will “return to normal” within a year, but does not exclude lifelong COVID jabs.